Inventor
KNUTSEN LARS J S
DK21 patents
⚠️ This page may combine multiple inventors who share the name “KNUTSEN LARS J S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVO NORDISK AS
9 patentsUS5589467ADec 31, 1996
2,5',N6-trisubstituted adenosine derivatives
NOVO NORDISK AS35 citations92
US5430027AJul 4, 1995
2-chloro-N6 -substituted adenosines, their pharmaceutical compositions, and activity in treating ischemias
NOVO NORDISK AS22 citations92
US5432164AJul 11, 1995
C2,N6 -disubstituted adenosine derivatives
NOVO NORDISK AS7 citations74
US5231106AJul 27, 1993
Azacyclic carboxylic acid derivatives and their preparation and use
NOVO NORDISK AS16 citations72
US5039685AAug 13, 1991
Azacyclic carboxylic acid derivatives, their preparation and use
NOVO NORDISK AS3 citations61
US5484774AJan 16, 1996
2, N6 -disubstituted adenosines, tri-O-ester derivatives and their pharmaceutical compositions to treat ischemias
NOVO NORDISK AS6 citations59
US5348965ASep 20, 1994
N-substituted azaheterocyclic carboxylic acids
NOVO NORDISK AS6 citations58
US5229404AJul 20, 1993
Azacyclic carboxylic acid derivatives and their preparation and use
NOVO NORDISK AS0 citations40
US5214054AMay 25, 1993
Azacyclic carboxylic acid derivatives and their preparation and use
NOVO NORDISK AS0 citations40
NMD PHARMA AS
6 patentsUS11730714B2Aug 22, 2023
Compounds for the treatment of neuromuscular disorders
NMD PHARMA AS2 citations65
US11591284B2Feb 28, 2023
Compounds for the treatment of neuromuscular disorders
NMD PHARMA AS2 citations64
US11147788B2Oct 19, 2021
Compounds for the treatment of neuromuscular disorders
NMD PHARMA AS2 citations64
US12415771B2Sep 16, 2025
Compounds for the treatment of neuromuscular disorders
NMD PHARMA AS0 citations46
US12440477B2Oct 14, 2025
Compounds for the treatment of neuromuscular disorders
NMD PHARMA AS0 citations44
US12168643B2Dec 17, 2024
Compounds for the treatment of neuromuscular disorders
NMD PHARMA AS0 citations41